Safety Rates Drug Report: REBETOL Hepatocellular carcinoma adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: REBETOL Injury: Hepatocellular carcinoma Quarter: 2016Q3

|< 1/2 << Previous Page Page 2

Total Records: 21 Number of Pages: 2

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
127123471	REBETOL	Hepatocellular carcinoma	MERCK	61.92 YR	M	74 KG	20160902	FR

|< 1/2 << Previous Page Page 2

Total Records: 21 Number of Pages: 2

Execution Time: 0.011663913726807 seconds (ucode:5134077). Developed by: James D. Barger